The Directorate General of Civil Aviation is considering expanding mandatory random drug testing for all commercial pilots to 100% annually [1].
This proposal follows a safety incident that has raised questions about cockpit sobriety and the adequacy of current screening protocols for flight crews.
The move comes after a turbulence incident on Aug. 4, 2024, during an Air India flight from Phuket, Thailand, to Delhi [2]. The event resulted in injuries to 24 passengers [3]. Following the incident, an initial screening indicated that a captain had tested positive for marijuana [1].
In response to the event, Air India conducted a one-time screening exercise of approximately 5,000 pilots [3]. That exercise resulted in two pilots returning non-negative initial drug test results [3].
Currently, the DGCA requires random drug testing for only 10% of pilots each year [1]. The proposed shift to 100% would ensure every commercial pilot is screened annually. However, some experts have raised concerns regarding the logistics of implementing such a comprehensive testing regime across the industry [1].
Civil Aviation Minister Ram Mohan Naidu and the DGCA continue to review the safety implications of the Phuket-Delhi flight [2]. While some reports state the captain tested positive, other records indicate the initial psychoactive-substance screening requires further confirmatory testing to be finalized [2].
“DGCA is considering expanding mandatory random drug testing for commercial pilots from the current 10% to 100% of pilots annually”
The proposal represents a significant shift in aviation oversight in India, moving from a sampling-based deterrent to a universal screening mandate. If implemented, the transition from a 10% to a 100% testing rate would place a substantial administrative and financial burden on airlines, while potentially increasing the detection of substance use in the cockpit.
